Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.
Clinical trial NCT07154238 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07154238
- Sponsor
- Novo Nordisk A/S
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-26
- Primary completion
- 2026-09-30
- Enrollment
- 2546
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.